Cyclo Therapeutics Inc.

NASDAQ: CYTH · Real-Time Price · USD
0.72
-0.00 (-0.08%)
At close: Mar 25, 2025, 3:59 PM

Cyclo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.25M 1.54M 16.61M
Short-Term Investments
n/a n/a n/a
Long-Term Investments
n/a n/a 7.28K
Other Long-Term Assets
n/a -56.66K n/a
Receivables
122.38K 54.99K 539.09K
Inventory
254.35K 254.49K 227.44K
Other Current Assets
n/a 2.31M n/a
Total Current Assets
12.32M 4.16M 19.44M
Property-Plant & Equipment
929.28K 56.66K 77.22K
Goodwill & Intangibles
n/a n/a n/a
Total Long-Term Assets
929.28K 56.66K 84.5K
Total Assets
13.25M 4.22M 19.52M
Account Payables
4.86M 2.23M 3.68M
Deferred Revenue
n/a n/a -3.68M
Short-Term Debt
n/a n/a 133.71K
Other Current Liabilities
1.59M 902.61K n/a
Total Current Liabilities
8.47M 3.48M 3.83M
Long-Term Debt
n/a n/a 18.03K
Other Long-Term Liabilities
n/a n/a n/a
Total Long-Term Liabilities
22.48K 3.48M 18.03K
Total Liabilities
8.49M 3.48M 3.85M
Total Debt
1.03M n/a 170.99K
Common Stock
2.86K 849.00 841.00
Retained Earnings
-83.86M -63.8M -48.35M
Comprehensive Income
n/a n/a n/a
Shareholders Equity
4.76M 734.54K 15.67M
Total Investments
n/a n/a 7.28K